AGRX - Why Agile Therapeutics Stock Is Falling Today
After sharing the pricing information of a just-announced common stock offering, Agile Therapeutics (NASDAQ: AGRX), a clinical-stage biopharma focused on women's health, saw its stock fall 14% as of 3:22 p.m. EST on Friday.
Agile announced on Thursday that it wanted to raise capital from a common stock offering. The company released the pricing details of the proposed offering today.
Agile stated that it is selling 15 million shares of stock at $3 per share. The underwriters of the deal are also being granted a 30-day option to purchase up to 2.25 million additional shares.